资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.

Cancer immunology research. 2019-12;

Sharma P,Harris DT,Stone JD,Kranz DM

Products/Services Used	Details	Operation
Peptide Synthesis	Peptides (anchor-modified, MART-1: ELAGIGILTV and single amino acid variants; WT1: RMFPNAPYL, UV-cleavable peptide: KILGFVFJV and various self-peptides (Supplementary Tables S1 and S2) were synthesized by GenScript Inc.	Get A Quote